These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21349360)

  • 1. Zinc toxicity: from "no, never" to "hardly ever".
    Roberts EA
    Gastroenterology; 2011 Apr; 140(4):1132-5. PubMed ID: 21349360
    [No Abstract]   [Full Text] [Related]  

  • 2. Zinc treatment for symptomatic Wilson disease: moving forward by looking back.
    Schilsky M
    Hepatology; 2009 Nov; 50(5):1341-3. PubMed ID: 19877301
    [No Abstract]   [Full Text] [Related]  

  • 3. A copper for your thoughts.
    Coates RA
    J Insur Med; 2012; 43(2):112-5. PubMed ID: 22876415
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of oral ZnSO4 on urine copper and blood trace elements in 60 patients with Wilson's disease].
    Yang RM
    Zhonghua Yi Xue Za Zhi; 1986 Apr; 66(4):211-3, 254. PubMed ID: 3094875
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview of health risk assessments for zinc.
    Boreiko CJ
    J Toxicol Environ Health A; 2010; 73(2):166-74. PubMed ID: 20077287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc mono-therapy in pre-symptomatic Chinese children with Wilson disease: a single center, retrospective study.
    Abuduxikuer K; Wang JS
    PLoS One; 2014; 9(1):e86168. PubMed ID: 24475083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
    Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the content of several microelements (copper, iron, zinc, manganese and molybdenum) in the blood and urine in hepato-cerebral dystrophy].
    Loĭko EA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):188-92. PubMed ID: 5655734
    [No Abstract]   [Full Text] [Related]  

  • 9. Axonal sensory motor neuropathy in copper-deficient Wilson's disease.
    Foubert-Samier A; Kazadi A; Rouanet M; Vital A; Lagueny A; Tison F; Meissner W
    Muscle Nerve; 2009 Aug; 40(2):294-6. PubMed ID: 19609919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal chelates of 2-hydroxy-4-methylthiobutanoic acid in animal feeding. Part 2: Further characterizations, in vitro and in vivo investigations.
    Predieri G; Elviri L; Tegoni M; Zagnoni I; Cinti E; Biagi G; Ferruzza S; Leonardi G
    J Inorg Biochem; 2005 Feb; 99(2):627-36. PubMed ID: 15621297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc treatment of Wilson's disease.
    Sandstead HH
    J Lab Clin Med; 1989 Dec; 114(6):615-6. PubMed ID: 2592852
    [No Abstract]   [Full Text] [Related]  

  • 12. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term follow-up of combined therapy with large-dose zinc sulfate and low-dose penicillamine in children with hepatolenticular degeneration].
    Li T; Lin R; Du S; Qu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Feb; 16(1):19-21. PubMed ID: 9949235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trace elements and DNA damage.
    O'Connor JM
    Biochem Soc Trans; 2001 May; 29(Pt 2):354-7. PubMed ID: 11356182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
    Günther K; Siegemund R; Lössner J; Kühn HJ
    Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
    Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
    J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric aspects of trace elements.
    Linter CM
    Br J Hosp Med; 1985 Dec; 34(6):361-5. PubMed ID: 4084706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical curative effects of dimercaptosuccinic acid on hepatolenticular degeneration and the impact of DMSA on biliary trace elements.
    Ren M; Yang R
    Chin Med J (Engl); 1997 Sep; 110(9):694-7. PubMed ID: 9642327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late presentation of Wilson's disease].
    Santander Vaquero C
    Rev Esp Enferm Dig; 2002 Aug; 94(8):502-3. PubMed ID: 12486857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.